4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one
TL;DR: 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one (CAS 6762-09-0) is a chemical compound with molecular formula C25H29N3O2 and molecular weight 403.23 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
4-[3-[4-(dimethylamino)phenyl]-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one
Also Known As: 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one, 4-[3-[4-(dimethylamino)phenyl]-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one, 4-{3-[4-(Dimethylamino)phenyl]-8-methoxy-1,3,4,5-tetrahydro-2H-benzo[g]indazol-2-yl}pent-3-en-2-one
| Molecular Formula | C25H29N3O2 |
|---|---|
| Molecular Weight | 403.23 g/mol |
| LogP | 4.4728 |
| Topological Polar Surface Area | 44.81 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Exact Mass | 403.22598 |
| Heavy Atoms | 30 |
| Complexity | 1034.8593 |
Chemical Identifiers
| CAS Number | 6762-09-0 |
|---|---|
| SMILES | CC(=CC(=O)C)N1C(C2=C(N1)C3=C(CC2)C=CC(=C3)OC)C4=CC=C(C=C4)N(C)C |
Product Overview
4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one (CAS 6762-09-0), with molecular formula C25H29N3O2 and molecular weight 403.23 g/mol. IUPAC: 4-[3-[4-(dimethylamino)phenyl]-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one.
Chemical Property Profile of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one
Property Insights of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one
The XLogP value of 4.4728 indicates that 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 44.81 Ų, 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one has 1 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one?
The CAS number of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one is 6762-09-0.
What is the molecular formula of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one?
The molecular formula of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one is C25H29N3O2.
What is the molecular weight of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one?
The molecular weight of 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one is 403.23 g/mol.
Where can I buy 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one?
You can request a quote for 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one?
Yes, KEHONG BIO provides custom synthesis services for 4-[3-(4-dimethylaminophenyl)-8-methoxy-1,3,4,5-tetrahydrobenzo[g]indazol-2-yl]pent-3-en-2-one and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.